Skip to main content


  • Monday, Aug 25th
    4:30 PM - 4:45 PM ET
    4B-02 - Analgesic Use and Risk of Renal Cell Carcinoma: Prospective Analysis in the Health Professionals Follow-up Study
    Presenting Author: Minji Jung – Stanford Medicine
    Co-Author: Jinhui Li – University of Illinois Chicago
    Co-Author: Marvin E. Langston – Stanford Medicine
    Co-Author: Benjamin I. Chung – Stanford Medicine
    Co-Author: Mark A. Preston – Brigham and Women's Hospital
    Co-Author: Rebecca E. Graff – University of California San Francisco
    Safety Outcomes / Cancer
  • Monday, Aug 25th
    5:15 PM - 5:30 PM ET
    4B-05 - Risk of respiratory and cardiovascular adverse events associated with gabapentinoid use among female breast cancer survivors in the United States: A new-user, active comparator cohort study
    Presenting Author: Jyun-Heng Lai, BPharm, MS – Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA
    Co-Author: Anton AvanceƱa, PhD – Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA
    Co-Author: Jamie Barner, PhD, FAACP, FAPhA – Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA
    Co-Author: Chanhyun Park, PhD., MPharm, MEd, RPh – Health Outcome Division, College of Pharmacy, University of Texas at Austin
    Co-Author: Kirk Evoy, PharmD, BCACP, BC-ADM, CTTS, FCCP, FTSHP – Pharmacotherapy and Translational Sciences Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA
    Co-Author: Jennifer Spencer, PhD – Department of Population Health, Dell Medical School, The University of Texas at Austin, Austin, TX, USA
    Safety Outcomes / Cancer